You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

T-cell Immunity

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Lung Transplant; Complications Trial in New York (device, diagnostic test, drug)

Not yet recruiting
  • Lung Transplant; Complications
  • Cytomegalovirus T Cell Immunity Panel (CMV-TCIP)
  • +2 more
  • New York, New York
    NYU Langone Health
Jan 24, 2023

CMV Antiviral T-cell Immunity Over Next Six Months Initiation of

Not yet recruiting
  • Kidney Transplant Infection
  • (no location specified)
Jan 23, 2023

COVID Vaccine Immunity in Kidney Transplant Recipients

Withdrawn
  • End Stage Renal Disease
  • Kidney Transplant; Complications
  • Coronavirus (COVID-19) SARS-CoV-2 inSIGHT™ T Cell Immunity Test
  • (no location specified)
Oct 25, 2022

"Don't Eat me" Signal in Hematological Malignancies: CD24 as New

Recruiting
  • Mantle-cell Lymphoma
  • B Cell Chronic Lymphocytic Leukemia
    • Monza, MB, Italy
      Andrea Aroldi
    May 24, 2023

    Viral Infection After HSCT Trial (Virus -specific T cells)

    Not yet recruiting
    • Viral Infection After HSCT
    • Virus -specific T cells
    • (no location specified)
    Mar 28, 2022

    Diffuse Large-Cell Lymphoma, Primary Mediastinal Large B-Cell Lymphoma (PMBCL), Transformed Follicular Lymphoma (TFL) Trial in

    Recruiting
    • Diffuse Large-Cell Lymphoma
    • +3 more
    • Pneumococcal conjugate vaccine (PCV13)
    • CD19 targeted CAR T Cell Therapy
    • Tampa, Florida
      Moffitt Cancer Center
    May 31, 2022

    COVID-19 Respiratory Infection, Influenza Trial in Tucson (COVID-19 Vaccine)

    Recruiting
    • COVID-19 Respiratory Infection
    • Influenza
    • COVID-19 Vaccine
    • Tucson, Arizona
      University of Arizona
    Sep 28, 2021

    Optimising Cohorts for HIV Cure Interventions

    Recruiting
    • HIV-1-infection
    • no intervention
    • Prahran, Victoria, Australia
      Alfred Health
    May 1, 2023

    Lymphoproliferative Disorders, Autoimmune Lymphoproliferative, Immune System Diseases Trial run by the NCI (drug, radiation,

    Recruiting
    • Lymphoproliferative Disorders
    • +4 more
    • Busulfan test dose
    • +8 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Jan 23, 2023

    Haematological Malignancies Trial in London, Manchester (CD25/71 allodepleted donor T-cells)

    Completed
    • Haematological Malignancies
    • CD25/71 allodepleted donor T-cells
    • London, United Kingdom
    • +1 more
    Jul 18, 2022

    Cytomegalovirus Viraemia Trial in Canada, Spain (Quantiferon-CMV assay)

    Completed
    • Cytomegalovirus Viraemia
    • Quantiferon-CMV assay
    • Edmonton, Alberta, Canada
    • +5 more
    Jul 29, 2022

    COVID-19 Vaccine and Other Vaccines'-Induced Immune Responses in

    Not yet recruiting
    • Follicular Lymphoma
    • Cellular immunity vs SARS-CoV-2
    • +6 more
    • Alessandria, IT, Italy
    • +13 more
    Oct 10, 2023

    Flu Vaccine Trial in Nashville (Fluzone-High Dose Quadrivalent, Fluad, Flublock)

    Completed
    Has Results
    • Flu Vaccine
    • Fluzone-High Dose Quadrivalent
    • +2 more
    • Nashville, Tennessee
      Vanderbilt University Medical Center
    Jun 16, 2022

    COVID-19 Respiratory Infection Trial (PD-1 and ACE2 Knockout T Cells)

    Not yet recruiting
    • COVID-19 Respiratory Infection
    • PD-1 and ACE2 Knockout T Cells
    • (no location specified)
    Aug 13, 2021

    Acute Myeloid Leukemia, High Risk Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, in Relapse Trial in Moscow (boost

    Recruiting
    • Acute Myeloid Leukemia
    • +6 more
    • boost anti-viral immunity after T-cell depleted HSCT
    • Moscow, Russian Federation
      Federal Research Center for pediatric hematology, oncology and i
    Oct 1, 2021

    Immunity, Innate, Colorectal Cancer Trial in Montreal (IVDD for NK cell activity in whole blood)

    Terminated
    • Immunity, Innate
    • Colorectal Cancer
    • IVDD for NK cell activity in whole blood
    • Montreal, Quebec, Canada
    • +2 more
    Jan 30, 2023

    Cytomegalovirus Infections Trial in Switzerland (T-Track® CMV assay)

    Completed
    • Cytomegalovirus Infections
    • T-Track® CMV assay
    • Basel, Switzerland
    • +4 more
    Apr 27, 2021

    Adenovirus, Cytomegalovirus Infections, Epstein-Barr Virus Infections Trial in Pittsburgh (Specific T- Lymphocytes)

    Not yet recruiting
    • Adenovirus
    • +2 more
    • Specific T- Lymphocytes
    • Pittsburgh, Pennsylvania
      UPMC Children's Hospital of Pittsburgh
    Sep 8, 2023

    Solid Tumor Trial (Tumor necrosis factor-thymosin alfa 1 recombinant (TNF-T), Tumor necrosis factor-thymosin alfa 1 recombinant

    Completed
    • Solid Tumor
    • Tumor necrosis factor-thymosin alfa 1 recombinant (TNF-T)
    • Tumor necrosis factor-thymosin alfa 1 recombinant (TNF-T) and chemotherapy
    • (no location specified)
    Jun 8, 2023

    Epigenetic Regulation of Altered T-cell Immunity in Sarcoidosis

    Recruiting
    • Sarcoidosis
    • Sarcoidosis, Pulmonary
    • Observational Study
    • San Francisco, California
      University of California, San Francisco (Parnassus)
    May 4, 2020

    Stage IV NSCLC Trial in Houston (Poly ICLC, IVIG)

    Not yet recruiting
    • Stage IV NSCLC
    • Houston, Texas
      Michael E. DeBakey VA Medical Center, Houston, TX
    Sep 28, 2023

    Intravenous Lidocaine and Immunity Trial in Montréal (intravenous lidocaine (IVL), Placebo)

    Recruiting
    • Intravenous Lidocaine and Immunity
    • intravenous lidocaine (IVL)
    • Placebo
    • Montréal, Quebec, Canada
      Hôpital Maisonneuve-Rosemont, CIUSSS de l'Est de l'Ile de Montré
    Oct 1, 2021

    Mumps, Measles, Rubella Trial in Zürich (MMR booster vaccination (as M-M-R-VaxPro))

    Not yet recruiting
    • Mumps
    • +2 more
    • MMR booster vaccination (as M-M-R-VaxPro)
    • Zürich, Switzerland
      Epidemiology, Biostatistics and Prevention Institute University
    Jun 8, 2023

    Hematologic Malignancy Trial in Bologna

    Recruiting
    • Hematologic Malignancy
      • Bologna, Italy
        Programma Dipartimentale Terapie Cellulari Avanzate
      Apr 17, 2023

      Manufacture of Clinical T-cell Products for Future Treatment

      Completed
      • Virus-specific T Cells
      • Leukapheresis
      • Basel, Switzerland
        University Hospital Basel, Departement Infektiologie & Spitalhyg
      Feb 3, 2023